Government Funding Incentives Presented By Richard Kun, RDP Associates Inc.
A single-arm phase II trial in p treated with C, D and B (15 mg/kg) every 3 weeks followed by B showed a promising efficacy, in terms of progression free.
frsbog_mim_v07_0015.pdf
